Article Text

Download PDFPDF
Systematic review and meta-analysis
Meta-analysis shows limited benefit of lowering blood pressure below 130/80 mm Hg in patients with type 2 diabetes
  1. Farrukh M Koraishy,
  2. Aldo J Peixoto
  1. VA Connecticut Healthcare System and Yale University School of Medicine, West Haven, Connecticut, USA
  1. Correspondence to Aldo J Peixoto
    VA Connecticut Healthcare System and Yale University School of Medicine, Medical Service—111F, 950 Campbell Avenue, West Haven, CT 06518, USA; aldo.peixoto{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMedWeb of Science


Although lowering blood pressure (BP) to the standard target of 140/90 mm Hg improves cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM), the benefits of more intensive lowering to <130/80 mm Hg have not been conclusively demonstrated. Despite this shortcoming, most current practice guidelines recommend this lower target. Two meta-analyses of studies evaluating outcomes according to the level of BP achieved in patients with diabetes1 ,2 or glucose intolerance1 demonstrated that tight BP control resulted in fewer strokes and albuminuria, but had no impact on other cardiovascular events or death.


The investigators evaluated five randomised clinical trials including 7312 patients with T2DM. The studies …

View Full Text


  • Competing interests None.